Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Let's Talk About Our Feelings!!! -- Ignore unavailable to you. Want to Upgrade?

To: coug who wrote (94076)	1/19/2005 10:48:12 PM
From: cosmicforce	Read Replies (2) \| Respond to of 108807

Hello coug, I have my doubts about aluminum too. It was well known that the users of iron pots caused people in old times to get too much iron, and for kids, toxic iron levels are quite dangerous. I'd be interested in knowing what your dad based it upon. So, what's that leave us? Stoneware? The glazes all have boron and the colors, well, that's just one heavy metal after another. It is unsafe to drink from heavily leaded glass but I see them sold at Costco and elsewhere for just such a purpose. Now Teflon is pretty inert so I guess you have to choose you poison as it were. I guess my main concern is that there is no credible challenge to the myriad chemicals that assault us daily. One would hope that's what the alphabet soup in DC does for us on a good day. There is no presumption of safety in Europe but they may have gone overboard. I sure felt better there though.

To: coug who wrote (94076)	1/20/2005 12:42:18 AM
From: Grainne	Read Replies (2) \| Respond to of 108807

Hi Coug! If you want to prevent Alzheimer's disease, it might be a good idea to eat a whole lot of turmeric (or curcumin), the yellow part of curry powder. I absolutely love Indian food, so this is great news for me! Curry Spice May Fight Alzheimer's Disease Early Studies Show Curry Reduces Plaque Buildup in Brain Linked to Disease By Kelli Miller Stacy WebMD Medical News Reviewed By Brunilda Nazario, MD on Wednesday, January 05, 2005 More From WebMD Trouble With Your Memory? Take Our Quiz to Rule Out Alzheimer's Get Alzheimer's and Nutrition News Delivered to Your Inbox Jan. 5, 2005 -- The compound that gives the popular Indian spice curry its mustard yellow color may ward off Alzheimer's disease. Researchers at UCLA have shown that the curry pigment curcumin slows the formation of, and even destroys, accumulated plaque deposits in mouse brains. Brain plaque, sticky clumps of beta-amyloid protein, are believed to play a key role in the development of Alzheimer's dementia. Curry is a dietary staple in India, a country where the rate of Alzheimer's disease is among the world's lowest. For centuries, doctors practicing traditional Indian medicine have safely prescribed curcumin in extract form for a variety of illnesses and ailments. Researchers say curry's powerful antioxidant and anti-inflammatory properties make it a very attractive possibility for treating diseases such as Alzheimer's, cancer, and heart disease. In studies looking at curcumin's potential as a chemopreventive therapy, no side effects were seen in patients taking as much as 2,000 to 8,000 mg per day. For this study, scientists raised two groups of mice, one that was fed a diet high in curcumin and the other a regular diet. Previous research in mice has shown that daily curcumin lowers plaque deposits in the brain. When fed to aged mice with advanced plaque deposits similar to Alzheimer's disease, the curcumin reduced the amount of plaque. The scientists then injected curcumin into the brains of the mice with the Alzheimer's-like condition. The curcumin attached to the plaques, hampering further development of plaque and reducing plaque levels. Moreover, in other experiments, the researchers showed that curcumin reduced plaque better than the over-the-counter painkillers naproxen and ibuprofen. Some studies have shown that people taking these common anti-inflammatories have a decreased risk of developing Alzheimer's disease. "The prospect of finding a safe and effective new approach to both prevention and treatment of Alzheimer's disease is tremendously exciting," Gregory Cole, MD, a professor of medicine and neurology at the David Geffen School of Medicine at UCLA, said in a news release. The results are published in the Journal of Biological Chemistry. The study was funded in part by the Alzheimer's Association. -------------------------------------------------------------------------------- SOURCES: News release, UCLA. Yang, F. Journal of Biological Chemistry, Dec. 7, 2004, online edition. my.webmd.com